In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis
- 1 March 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (3), 432-437
- https://doi.org/10.1128/aac.38.3.432
Abstract
We evaluated the in vivo activity and the diffusion of radiolabelled RP 57669 (RPI) and RP 54476 (RPII), the two components of the injectable streptogramin RP 59500, alone or in combination, in aortic vegetations from experimental endocarditis in rabbits. RPI and RPII demonstrated in vitro bacteriostatic and bactericidal synergy against a clinical strain of Staphylococcus aureus resistant to methicillin and susceptible to erythromycin. In experimental staphylococcal endocarditis, RP 59500 was as effective as vancomycin and significantly more effective than RPI (P < 0.01) and RPII (P < 0.05). Autoradiography studies showed different patterns of distribution into cardiac vegetations infected with Streptococcus sanguis for [14C]RPI and [14C]RPII. [14C]RPI was homogeneously distributed throughout the vegetations whereas [14C]RPII showed a decreasing gradient of concentration between the periphery and the core of the vegetation, with an approximately 2:1 ratio. [14C]RPI diffused approximately 2 to 4 times more than [14C]RPII into the core of the vegetations. Since the injected ratio of RPI and RPII is 30:70 in RP 59500, the actual RPI:RPII ratio in the core of the vegetation may range from 0.8 to 1.7, a ratio which remains compatible with the in vivo synergism demonstrated between the two components.Keywords
This publication has 14 references indexed in Scilit:
- In vitro antistaphylococcal activity and testing of RP 59500, a new streptogramin, by two methodsAntimicrobial Agents and Chemotherapy, 1992
- In-vitro and in-vivo synergic activity and fractional inhibitory concentration (FIC of the components of a semisynthetic streptogramin, RP 59500Journal of Antimicrobial Chemotherapy, 1992
- A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500Journal of Antimicrobial Chemotherapy, 1992
- Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1992
- Post-antibiotic effects of RP 59500 with Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1992
- Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faeciumAntimicrobial Agents and Chemotherapy, 1991
- Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative AutoradiographyThe Journal of Infectious Diseases, 1989
- WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1989
- 3H-Spiramycin penetration into fibrin vegetations in an experimental model of streptococcal endocarditisJournal of Antimicrobial Chemotherapy, 1988
- Method of reliable determination of minimal lethal antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1980